GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Interest Expense

Rapid Dose Therapeutics (XCNQ:DOSE) Interest Expense : C$-0.95 Mil (TTM As of Aug. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Rapid Dose Therapeutics's interest expense for the three months ended in Aug. 2024 was C$ -0.24 Mil. Its interest expense for the trailing twelve months (TTM) ended in Aug. 2024 was C$-0.95 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Rapid Dose Therapeutics's Operating Income for the three months ended in Aug. 2024 was C$ -0.86 Mil. Rapid Dose Therapeutics's Interest Expense for the three months ended in Aug. 2024 was C$ -0.24 Mil. Rapid Dose Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Rapid Dose Therapeutics Interest Expense Historical Data

The historical data trend for Rapid Dose Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Interest Expense Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -0.14 -0.13 -0.27 -0.66

Rapid Dose Therapeutics Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.10 -0.31 -0.30 -0.24

Rapid Dose Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics  (XCNQ:DOSE) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Rapid Dose Therapeutics's Interest Expense for the three months ended in Aug. 2024 was C$-0.24 Mil. Its Operating Income for the three months ended in Aug. 2024 was C$-0.86 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Aug. 2024 was C$2.37 Mil.

Rapid Dose Therapeutics's Interest Coverage for the quarter that ended in Aug. 2024 is calculated as

Rapid Dose Therapeutics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Rapid Dose Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Interest Expense
Comparable Companies
TSXV:IBT TSXV:SBM TSXV:COV TSXV:CZO TSX:APS TSX:MDNA TSX:RVX TSX:TH TSXV:NRX NEOE:BMND OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
RDTCF:USA
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Website
https://www.rapid-dose.com
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Executives
Mark Upsdell Director
Brian Howlett Director

Rapid Dose Therapeutics Headlines

No Headlines